APCER Pharma to Demonstrate Cost-Effective Drug Safety, Regulatory Services and Risk Management Solutions for Generic Pharmaceutical Companies at the GPhA
2/16/2010 10:01:33 AM
PRINCETON, N.J.--(BUSINESS WIRE)--APCER PHARMA (“APCER”) executives will discuss and demonstrate their expertise in providing generic drug manufacturers with the best in class pharmacovigilance/drug safety, regulatory and risk management services at the GPhA Annual Meeting, February 16-18, at the Ritz-Carlton in Naples, Florida. APCER will be in Booth #27.
comments powered by